Immunovant, Inc. (IMVT)
37.02
+0.37
(+1.01%)
USD |
NASDAQ |
Sep 16, 13:23
Immunovant 1 Year Total Returns (Daily) : 136.0% for Sept. 15, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 15, 2026 | 136.0% |
| September 14, 2026 | 133.0% |
| September 11, 2026 | 122.4% |
| September 10, 2026 | 135.2% |
| September 09, 2026 | 136.3% |
| September 08, 2026 | 141.7% |
| September 04, 2026 | 143.5% |
| September 03, 2026 | 134.3% |
| September 02, 2026 | 162.0% |
| September 01, 2026 | 171.6% |
| August 31, 2026 | 177.9% |
| August 28, 2026 | 178.0% |
| August 27, 2026 | 188.7% |
| August 26, 2026 | 191.0% |
| August 25, 2026 | 192.1% |
| August 24, 2026 | 184.3% |
| August 21, 2026 | 199.0% |
| August 20, 2026 | 199.3% |
| August 19, 2026 | 203.4% |
| August 18, 2026 | 190.3% |
| August 17, 2026 | 187.2% |
| August 14, 2026 | 175.1% |
| August 13, 2026 | 163.2% |
| August 12, 2026 | 180.1% |
| August 11, 2026 | 177.3% |
| Date | Value |
|---|---|
| August 10, 2026 | 158.0% |
| August 07, 2026 | 154.0% |
| August 06, 2026 | 149.0% |
| August 05, 2026 | 137.9% |
| August 04, 2026 | 144.6% |
| August 03, 2026 | 145.1% |
| July 31, 2026 | 140.2% |
| July 30, 2026 | 137.5% |
| July 29, 2026 | 131.9% |
| July 28, 2026 | 132.1% |
| July 27, 2026 | 136.5% |
| July 24, 2026 | 115.1% |
| July 23, 2026 | 114.1% |
| July 22, 2026 | 117.7% |
| July 21, 2026 | 123.3% |
| July 20, 2026 | 122.9% |
| July 17, 2026 | 120.2% |
| July 16, 2026 | 118.8% |
| July 15, 2026 | 128.0% |
| July 14, 2026 | 108.6% |
| July 13, 2026 | 113.5% |
| July 10, 2026 | 126.9% |
| July 09, 2026 | 137.7% |
| July 08, 2026 | 138.7% |
| July 07, 2026 | 144.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Moderna, Inc. | 502.1% |
| Altimmune, Inc. | -10.03% |
| TG Therapeutics, Inc. | 67.06% |
| Dianthus Therapeutics, Inc. | 182.9% |
| First Tracks Biotherapeutics, Inc. | -- |